Your browser doesn't support javascript.
loading
Morphometric Analysis of Explant Lungs in Cystic Fibrosis.
Boon, Mieke; Verleden, Stijn E; Bosch, Barbara; Lammertyn, Elise J; McDonough, John E; Mai, Cindy; Verschakelen, Johny; Kemner-van de Corput, Mariette; Tiddens, Harm A W; Proesmans, Marijke; Vermeulen, François L; Verbeken, Erik K; Cooper, Joel; Van Raemdonck, Dirk E; Decramer, Marc; Verleden, Geert M; Hogg, James C; Dupont, Lieven J; Vanaudenaerde, Bart M; De Boeck, Kris.
Afiliación
  • Boon M; 1 Pediatric Pulmonology and Cystic Fibrosis Unit, Department of Pediatrics.
  • Verleden SE; 2 Lung Transplant Unit, Laboratory of Pulmonology, Department of Clinical and Experimental Medicine, KU Leuven-University of Leuven, Leuven, Belgium.
  • Bosch B; 1 Pediatric Pulmonology and Cystic Fibrosis Unit, Department of Pediatrics.
  • Lammertyn EJ; 2 Lung Transplant Unit, Laboratory of Pulmonology, Department of Clinical and Experimental Medicine, KU Leuven-University of Leuven, Leuven, Belgium.
  • McDonough JE; 2 Lung Transplant Unit, Laboratory of Pulmonology, Department of Clinical and Experimental Medicine, KU Leuven-University of Leuven, Leuven, Belgium.
  • Mai C; 3 Department of Pulmonary Radiology, and.
  • Verschakelen J; 3 Department of Pulmonary Radiology, and.
  • Kemner-van de Corput M; 4 Department of Radiology and.
  • Tiddens HA; 4 Department of Radiology and.
  • Proesmans M; 5 Department of Paediatrics, Respiratory Medicine and Allergology, Erasmus MC, Rotterdam, the Netherlands.
  • Vermeulen FL; 1 Pediatric Pulmonology and Cystic Fibrosis Unit, Department of Pediatrics.
  • Verbeken EK; 1 Pediatric Pulmonology and Cystic Fibrosis Unit, Department of Pediatrics.
  • Cooper J; 6 Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Van Raemdonck DE; 7 Department of Thoracic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania; and.
  • Decramer M; 2 Lung Transplant Unit, Laboratory of Pulmonology, Department of Clinical and Experimental Medicine, KU Leuven-University of Leuven, Leuven, Belgium.
  • Verleden GM; 2 Lung Transplant Unit, Laboratory of Pulmonology, Department of Clinical and Experimental Medicine, KU Leuven-University of Leuven, Leuven, Belgium.
  • Hogg JC; 2 Lung Transplant Unit, Laboratory of Pulmonology, Department of Clinical and Experimental Medicine, KU Leuven-University of Leuven, Leuven, Belgium.
  • Dupont LJ; 8 University of British Columbia James Hogg Research Centre, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Vanaudenaerde BM; 2 Lung Transplant Unit, Laboratory of Pulmonology, Department of Clinical and Experimental Medicine, KU Leuven-University of Leuven, Leuven, Belgium.
  • De Boeck K; 2 Lung Transplant Unit, Laboratory of Pulmonology, Department of Clinical and Experimental Medicine, KU Leuven-University of Leuven, Leuven, Belgium.
Am J Respir Crit Care Med ; 193(5): 516-26, 2016 Mar 01.
Article en En | MEDLINE | ID: mdl-26551917
ABSTRACT
RATIONALE After repeated cycles of lung infection and inflammation, patients with cystic fibrosis (CF) evolve to respiratory insufficiency. Although histology and imaging have provided descriptive information, a thorough morphometric analysis of end-stage CF lung disease is lacking.

OBJECTIVES:

To quantify the involvement of small and large airways in end-stage CF.

METHODS:

Multidetector computed tomography (MDCT) and micro-CT were applied to 11 air-inflated CF explanted lungs and 7 control lungs to measure, count, and describe the airway and parenchymal abnormalities in end-stage CF lungs. Selected abnormalities were further investigated with thin section histology. MEASUREMENTS AND MAIN

RESULTS:

On MDCT, CF explanted lungs showed an increased median (interquartile range) number (631 [511-710] vs. 344 [277-349]; P = 0.003) and size of visible airways (cumulative airway diameter 217 cm [209-250] vs. 91 cm [80-105]; P < 0.001) compared with controls. Airway obstruction was seen, starting from generation 6 and increasing to 40 to 50% of airways from generation 9 onward. Micro-CT showed that the total number of terminal bronchioles was decreased (2.9/ml [2.6-4.4] vs. 5.3/ml [4.8-5.7]; P < 0.001); 49% were obstructed, and the cross-sectional area of the open terminal bronchioles was reduced (0.093 mm(2) [0.084-0.123] vs. 0.179 mm(2) [0.140-0.196]; P < 0.001). On micro-CT, 41% of the obstructed airways reopened more distally. This remodeling was confirmed on histological analysis. Parenchymal changes were also seen, mostly in a patchy and peribronchiolar distribution.

CONCLUSIONS:

Extensive changes of dilatation and obstruction in nearly all airway generations were observed in end-stage CF lung disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Pulmón / Fibrosis Quística / Obstrucción de las Vías Aéreas / Remodelación de las Vías Aéreas (Respiratorias) / Pulmón Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Pulmón / Fibrosis Quística / Obstrucción de las Vías Aéreas / Remodelación de las Vías Aéreas (Respiratorias) / Pulmón Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2016 Tipo del documento: Article